Anas Al Bawaliz
Hematology & Oncology · Louisville, KYNPI 1518452127
Payments from drug & device makers
Across 139 payments — averaging $21.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$387
- Daiichi Sankyo Inc.$300
- E.r. Squibb & Sons, L.L.C.$250
- Amgen$232
- Seagen Inc.$181
- Genentech USA, Inc.$148
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,81394%
- Education$1756%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 18 | $387 |
| Daiichi Sankyo Inc. | 13 | $300 |
| E.r. Squibb & Sons, L.L.C. | 15 | $250 |
| Amgen | 9 | $232 |
| Seagen Inc. | 12 | $181 |
| Genentech USA, Inc. | 1 | $148 |
| Pfizer | 6 | $140 |
| AbbVie | 7 | $133 |
| Sobi, Inc | 5 | $105 |
| Merck | 6 | $100 |
| Rigel Pharmaceuticals, Inc. | 4 | $95 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $93 |
| AVEO Pharmaceuticals, Inc. | 1 | $75 |
| Bayer | 3 | $72 |
| AstraZeneca(2 entities) | 3 | $69 |
| Pharmacosmos Therapeutics Inc. | 3 | $66 |
| Beigene USA, Inc. | 4 | $55 |
| ADC Therapeutics America, Inc. | 3 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Johnson & Johnson | 2 | $47 |
| Boehringer Ingelheim | 3 | $43 |
| Incyte Corporation | 2 | $42 |
| Stemline Therapeutics Inc. | 2 | $38 |
| Mirati Therapeutics, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Sanofi | 1 | $27 |
| Gilead | 1 | $25 |
| Adaptive Biotechnologies Corporation | 1 | $23 |
| Eisai Inc. | 1 | $20 |
| Puma Biotechnology, Inc. | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Apellis Pharmaceuticals, Inc. | 1 | $16 |
How this compares
$2,988 in reported general payments places this provider in the 25th percentile of 143 hematology & oncology providers in Kentucky.
Other hematology & oncology in Louisville
- Joseph MalyLouisville$7M
- Laila AgrawalLouisville$6.3M
- Jaspreet GrewalLouisville$4.2M
- Rebecca RedmanLouisville$2.1M
- Vivek SharmaLouisville$1.9M
- Rohit KumarLouisville$1.6M
- Jeffrey HargisLouisville$1.3M
- Goetz KloeckerLouisville$1.2M
- Elizabeth RileyLouisville$746K
- Adam LyeLouisville$706K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.